Latest Trials Latest NewsFAQ

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers

Phase 2

Withdrawn

Conditions: Diabetes
Hypertension
Obesity

Interventions: Drug: Twenty-four Hour TPN and Saline Infusion

First Posted Date: 2009-10-05

Last Posted Date: 2014-07-04

Lead Sponsor: Emory University

Registration Number: NCT00989339

Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Bortezomib and Tipifarnib

First Posted Date: 2009-09-07

Last Posted Date: 2015-03-10

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT00972712

Locations: 🇺🇸
City of Hope Cancer Institute, Duarte, California, United States
🇨🇦
Princess Margaret Cancer Center, Toronto, Ontario, Canada
🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States

Surgical Planning for Reconstruction of Complex Heart Defects

Completed

Conditions: Double Outlet Right Ventricle

First Posted Date: 2009-09-07

Last Posted Date: 2022-01-11

Lead Sponsor: Emory University

Target Recruit Count: 66

Registration Number: NCT00972608

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Georgia Institute of Technology, Atlanta, Georgia, United States

Intraosseous Infusion of Unrelated Cord Blood Grafts

Not Applicable

Terminated

Conditions: Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions: Procedure: cord blood infusion

First Posted Date: 2009-08-28

Last Posted Date: 2013-11-27

Lead Sponsor: Emory University

Target Recruit Count: 5

Registration Number: NCT00967525

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Micronutrient Sprinkles in a Daycare Center

Phase 3

Completed

Conditions: Diarrhea
Respiratory Infection

Interventions: Dietary Supplement: Micronutrient sprinkles without zinc
Dietary Supplement: Micronutrient Sprinkles with zinc

First Posted Date: 2009-08-28

Last Posted Date: 2013-04-11

Lead Sponsor: Emory University

Target Recruit Count: 143

Registration Number: NCT00967551

Locations: 🇧🇷
Universidade Federal da Bahia, Complexo Hospitalar Universitário Professor Edgar Santos, Centro de Pesquisa Fima Lifshitz, Salvador, Bahia, Brazil

Sickle Cell Disease Conditioning for Bone Marrow Transplant

Phase 1

Completed

Conditions: Bone Marrow Transplantation
Sickle Cell Disease

Interventions: Drug: fludarabine

First Posted Date: 2009-08-28

Last Posted Date: 2017-07-25

Lead Sponsor: Emory University

Target Recruit Count: 8

Registration Number: NCT00968162

Locations: 🇺🇸
University of Texas Southwestern, Dallas, Texas, United States
🇺🇸
Tulane University, New Orleans, Louisiana, United States
🇺🇸
Children's National Medical Center, Washington, D.C., District of Columbia, United States

and more 7 locations

Prevention of Cystic Fibrosis Diabetes

Phase 3

Terminated

Conditions: Cystic Fibrosis
Prediabetes

Interventions: Drug: Sitagliptin

First Posted Date: 2009-08-28

Last Posted Date: 2018-06-25

Lead Sponsor: Emory University

Target Recruit Count: 33

Registration Number: NCT00967798

Locations: 🇺🇸
Emory University and Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta at Scottish Rite, Atlanta, Georgia, United States
🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

Not Applicable

Terminated

Conditions: High Risk Solid Tumors
Recurrent Solid Tumors

Interventions: Procedure: Peripheral Blood Stem Cell Transplant

First Posted Date: 2009-08-27

Last Posted Date: 2013-12-11

Lead Sponsor: Emory University

Target Recruit Count: 3

Registration Number: NCT00966498

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)

Phase 1

Completed

Conditions: Malignancy
Bone Marrow Transplantation

Interventions: Drug: Rifaximin

First Posted Date: 2009-08-27

Last Posted Date: 2013-11-27

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT00967096

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Comparison of Infection Rates Among Patients Using Two Catheter Access Devices

Completed

Conditions: Bacteremia
Catheter-Related Infections

First Posted Date: 2009-08-25

Last Posted Date: 2013-11-21

Lead Sponsor: Emory University

Target Recruit Count: 10000

Registration Number: NCT00965198

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy